Development Of Chitosan Nanoparticles Coated With Hyaluronic Acid For Topical Ocular Delivery Of Dexamethasone.
M. A. Kalam
Published 2016 · Medicine, Chemistry
Download PDFAnalyze on Scholarcy
The present study involved design of dexamethasone-sodium phosphate (DEX) loaded mucoadhesive chitosan nanoparticles for topical ocular delivery to improve its precorneal retention and corneal permeability. The chitosan-sodium tripolyphosphate nanoparticle (CS-NPs) was developed through ionotropic-gelation technique. The developed CS-NPs were coated with hyaluronic-acid (HA) to make discrete, free-flowing NPs and to improve their mucoadhesive characteristics. The particle-size, zeta-potential and polydispersity-index were determined by Malvern-Zetasizer. The average size of the CS-NPs ranged from 305.25±14.29nm (without HA-coating and before freeze-drying) to 400.57±15.23nm (HA-coated and after freeze-drying). Due to the polyanionic nature of HA, reversing of zeta-potentials from +32.55±4.15 to -33.74±3.45 was observed. Polydispersity-indices varied from 0.178±0.067 (before freeze-drying of HA-coated F2) to 0.427±0.028 (after freeze-drying of HA-coated F2). The encapsulation and loading capacity of around 72.95% and 14.51% respectively were found in optimized CS-NPs. In simulated tear fluid 75.84% cumulative amount of released drug was detected and the in-vitro release results suggested the mechanism of drug release was Fickian-diffusion type. The clarity, pH, refractive index, surface tension and viscosity of the suspensions of DEX-CS-NPs were found promising for ocular use. Stability study on nanoparticles revealed no significant changes were observed in particle-size, encapsulation, drug release and physicochemical characteristics at 25°C for 3-months storage.
This paper references
Chitosan based nanocarriers for indomethacin ocular delivery
A. Badawi (2008)
Chitosan: antimicrobial activity, interactions with food components and applicability as a coating on fruit and vegetables
F. Devlieghere (2004)
Physicochemical characterization of epigallocatechin gallate lipid nanoparticles (EGCG-LNs) for ocular instillation.
J. Fangueiro (2014)
Kinetics of γ‐cyclodextrin nanoparticle suspension eye drops in tear fluid
G. Jóhannesson (2014)
Thermoresponsive ophthalmic poloxamer/tween/carbopol in situ gels of a poorly water-soluble drug fluconazole: preparation and in vitro–in vivo evaluation
Wang Li-hong (2014)
Chromatographic Applications on Monolithic Columns: Determination of Triamcinolone, Prednisolone and Dexamethasone in Pharmaceutical Tablet Formulations Using a Solid Phase Extraction and a Monolithic Column
H. Hashem (2005)
Evaluation of different factors affecting antimicrobial properties of chitosan.
M. Hosseinnejad (2016)
Preparation and characterization of a collagen/chitosan/heparin matrix for an implantable bioartificial liver
X. Wang (2005)
CD44-mediated uptake and degradation of hyaluronan.
W. Knudson (2002)
Nanostructured lipid carrier (NLC) coated with Chitosan Oligosaccharides and its potential use in ocular drug delivery system.
Qiuhua Luo (2011)
The storage stability of chitosan/tripolyphosphate nanoparticles in a phosphate buffer
Min Lang Tsai (2011)
MECHANISM OF SUSTAINED-ACTION MEDICATION. THEORETICAL ANALYSIS OF RATE OF RELEASE OF SOLID DRUGS DISPERSED IN SOLID MATRICES.
T. Higuchi (1963)
Improved intraocular bioavailability of ganciclovir by mucoadhesive polymer based ocular microspheres: development and simulation process in Wistar rats
Usha Ganganahalli Kapanigowda (2015)
The effect of a PEG versus a chitosan coating on the interaction of drug colloidal carriers with the ocular mucosa.
A. M. de Campos (2003)
Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP).
Y. Diebold (2007)
Topical dexamethasone-cyclodextrin microparticle eye drops for diabetic macular edema.
M. Tanito (2011)
The effect of chitin and chitosan on the proliferation of human skin fibroblasts and keratinocytes in vitro.
G. Howling (2001)
Corneal gene therapy.
E. Klausner (2007)
Solid lipid nanoparticles for ocular drug delivery
A. Seyfoddin (2010)
Cyclodextrin solubilization of carbonic anhydrase inhibitor drugs: formulation of dorzolamide eye drop microparticle suspension.
P. Jansook (2010)
Mathematical modeling of bioerodible, polymeric drug delivery systems.
J. Siepmann (2001)
Layer by layer buildup of polysaccharide films: physical chemistry and cellular adhesion aspects.
L. Richert (2004)
Chitosans as Absorption Enhancers for Poorly Absorbable Drugs 2: Mechanism of Absorption Enhancement
N. G. Schipper (2004)
Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A.
A. M. de Campos (2001)
Chitosan nanoparticles for drug delivery to the eye
Patrizia Paolicelli (2009)
HA-coated chitosan nanoparticles for CD44-mediated nucleic acid delivery.
Abdulaziz Almalik (2013)
Bioadhesive hyaluronan–chitosan nanoparticles can transport genes across the ocular mucosa and transfect ocular tissue
M. Fuente (2008)
Effect of chitosan on epithelial permeability and structure.
V. Dodane (1999)
Hyaluronic acid-coated chitosan nanoparticles: molecular weight-dependent effects on morphology and hyaluronic acid presentation.
Abdulaziz Almalik (2013)
Chitosan as tear substitute: a wetting agent endowed with antimicrobial efficacy.
O. Felt (2000)
Physicochemical characterization of chitosan nanoparticles: electrokinetic and stability behavior.
T. López-León (2005)
Impact of chitosan composites and chitosan nanoparticle composites on various drug delivery systems: A review.
M. A. Elgadir (2015)
Synthesis and fungicidal activity of new N,O-acyl chitosan derivatives.
M. E. Badawy (2004)
Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells.
R. E. Eliaz (2001)
The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan
M. Culty (1992)
Microspheres and nanoparticles used in ocular delivery systems
A. Zimmer (1995)
Chitosan and Chitosan/Ethylene Oxide-Propylene Oxide Block Copolymer Nanoparticles as Novel Carriers for Proteins and Vaccines
P. Calvo (2004)
Chitosan Nanoparticles as New Ocular Drug Delivery Systems: in Vitro Stability, in Vivo Fate, and Cellular Toxicity
A. M. de Campos (2004)
Chitosan nanoparticles: preparation, size evolution and stability.
A. Rampino (2013)
Novel hyaluronic acid-chitosan nanoparticles for ocular gene therapy.
M. de la Fuente (2008)
Effects of chitosan coating on shelf-life of ready-to-cook meat products during chilled storage
Sweetie R. Kanatt (2013)
Recent advances on chitosan-based micro- and nanoparticles in drug delivery.
S. Agnihotri (2004)
Endogenous hyaluronan in the anterior segment of the eye
P. Fagerholm (1996)
Enhanced Trans-Corneal Permeability of Valacyclovir by Polymethacrylic Acid Copolymers Based Ocular Microspheres: In Vivo Evaluation of Estimated Pharmacokinetic/Pharmacodynamic Indices and Simulation of Aqueous Humor Drug Concentration-Time Profile
Usha Ganganahalli Kapanigowda (2015)
Effect of chitosan on in vitro release and ocular delivery of ofloxacin from erodible inserts based on poly(ethylene oxide).
G. Di Colo (2002)
Topical dexamethasone γ‐cyclodextrin nanoparticle eye drops increase visual acuity and decrease macular thickness in diabetic macular oedema
A. Ohira (2015)
Recent advances in ocular drug delivery
Djamila Achouri (2013)
Hyaluronic acid (HA) presentation as a tool to modulate and control the receptor-mediated uptake of HA-coated nanoparticles.
Abdulaziz Almalik (2013)
Synergistic interaction between TS-polysaccharide and hyaluronic acid: implications in the formulation of eye drops.
Gloria Uccello-Barretta (2010)
Hyaluronan and CD44 in the human cornea and limbal conjunctiva.
L. Lerner (1998)
Topical semi-solid drug delivery: kinetics and tolerance of ophthalmic hydrogels
M. Zignani (1995)
Part I: Development and optimization of solid-lipid nanoparticles using Box-Behnken statistical design for ocular delivery of gatifloxacin.
Mohd Abul Kalam (2013)
Mucoadhesive nano-sized supramolecular assemblies for improved pre-corneal drug residence time
Angela Fabiano (2015)
Expression of adhesion molecule CD44 on human corneas
S. N. Zhu (1997)
Encapsulation of dexamethasone into biodegradable polymeric nanoparticles.
Carolina Gómez-Gaete (2007)
Dexamethasone/PLGA microspheres for continuous delivery of an anti-inflammatory drug for implantable medical devices.
T. Hickey (2002)
Evaluation of cationic polymer-coated nanocapsules as ocular drug carriers
P. Calvo (1997)
The potential of chitosan in ocular drug delivery.
M. Alonso (2003)
Bioadhesive microspheres for ophthalmic administration of acyclovir.
I. Genta (1997)
Determination of dexamethasone sodium phosphate in the vitreous by high performance liquid chromatography.
H. W. Kwak (1995)
Topical and systemic absorption in delivery of dexamethasone to the anterior and posterior segments of the eye.
H. Sigurdsson (2007)
Chitosan as an ocular drug delivery vehicle for vancomycin
Anutra Khangtragool (2011)
C. Lemarchand (2004)
Chitin/chitosan: modifications and their unlimited application potential—an overview
K. H. Prashanth (2007)
Optimizing indomethacin-loaded chitosan nanoparticle size, encapsulation, and release using Box-Behnken experimental design.
Mohd Abul Kalam (2016)
Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery.
Quan Gan (2005)
Eudragit RS100 nanosuspensions for the ophthalmic controlled delivery of ibuprofen.
R. Pignatello (2002)
Evaluation of an in situ forming hydrogel wound dressing based on oxidized alginate and gelatin.
B. Balakrishnan (2005)
Chitosan/TPP and Chitosan/TPP-hyaluronic Acid Nanoparticles: Systematic Optimisation of the Preparative Process and Preliminary Biological Evaluation
A. Nasti (2009)
Effect of Chitosan on the Permeability of Monolayers of Intestinal Epithelial Cells (Caco-2)
P. Artursson (2004)
This paper is referenced by
Polysaccharide Containing Gels for Pharmaceutical Applications
Catalina Natalia Cheaburu-Yilmaz (2018)
Mucoadhesive Micro-/Nano Carriers in Ophthalmic Drug Delivery: an Overview
Jitendra B. Naik (2020)
New nanoparticles for topical ocular delivery of erythropoietin.
B. Silva (2020)
In Vitro and Ex Vivo Evaluation of Nepafenac-Based Cyclodextrin Microparticles for Treatment of Eye Inflammation
Blanca Lorenzo-Veiga (2020)
Olopatadine hydrochloride loaded Kollidon® SR nanoparticles for ocular delivery: Nanosuspension formulation and in vitro–in vivo evaluation
Umay Merve Güven (2019)
Employing a PLGA-TPGS based nanoparticle to improve the ocular delivery of Acyclovir
Musaed Alkholief (2019)
Effect of cryoprotection on particle size stability and preservation of chitosan nanoparticles with and without hyaluronate or alginate coating
Abdulaziz M Almalik (2017)
Self-nanoemulsifying drug delivery system of nabumetone improved its oral bioavailability and anti-inflammatory effects in rat model
Sadaf Chaudhary (2019)
Improving the topical ocular pharmacokinetics of an immunosuppressant agent with mucoadhesive nanoemulsions: Formulation development, in-vitro and in-vivo studies.
Sohail Akhter (2016)
High drug payload nanoparticles formed from dexamethasone-peptide conjugates for the treatment of endotoxin-induced uveitis in rabbit
Xinxin Yu (2019)
Sustained release timolol maleate loaded ocusert based on biopolymer composite.
Revathy V. Nair (2018)
pH-Activated surface charge-reversal double-crosslinked hyaluronic acid nanogels with feather keratin as multifunctional crosslinker for tumor-targeting DOX delivery.
Hongpeng Zhang (2019)
Nanoencapsulation of betamethasone valerate using high pressure homogenization–solvent evaporation technique: optimization of formulation and process parameters for efficient dermal targeting
Shadab Md (2019)
Development and characterization of nanostructured lipid carriers based chitosan thermosensitive hydrogel for delivery of dexamethasone.
Guoxin Tan (2017)
Carbamoylethyl pullulan: QbD based synthesis, characterization and corneal wound healing potential.
Ram Sarup Singh (2018)
Novel biodegradable nanocarriers for enhanced drug delivery.
M. Gagliardi (2016)
Bioadhesive chitosan-loaded liposomes: A more efficient and higher permeable ocular delivery platform for timolol maleate.
Guoxin Tan (2017)
An innovative polysaccharide nanobased nail formulation for improvement of onychomycosis treatment
Fernanda Cramer Flores (2017)
Preparation of barley and yeast β-glucan scaffolds by hydrogel foaming: evaluation of dexamethasone release
Marta Morgade Salgado (2017)
Corneal permeation properties of a charged lipid nanoparticle carrier containing dexamethasone
Junfeng Ban (2017)
Hyaluronic acid decorated tacrolimus-loaded nanoparticles: Efficient approach to maximize dermal targeting and anti-dermatitis efficacy.
Fan Zhuo (2018)
Poly (d, l-lactide-co-glycolide) nanoparticles for sustained release of tacrolimus in rabbit eyes.
M. A. Kalam (2017)
A Comparative Study of Levocetirizine Loaded Vesicular and Matrix Type System for Topical Application: Appraisal of Therapeutic Potential against Atopic Dermatitis
Ravi Raj Pal (2020)
Chitosan and its Derivatives for Ocular Delivery Formulations: Recent Advances and Developments
Alexandra Zamboulis (2020)
Pharmaceutical technology can turn a traditional drug, dexamethasone into a first-line ocular medicine. A global perspective and future trends.
Javier Rodríguez Villanueva (2017)
Synthesis and characterization of hyaluronic acid coated manganese dioxide microparticles that act as ROS scavengers.
J. Bizeau (2017)
Novel nanosystems for the treatment of ocular inflammation: Current paradigms and future research directions
Lida Lalu (2017)
Chitosan nanoparticles making their way to clinical practice: A feasibility study on their topical use for acne treatment.
Hend A. Abdallah (2020)
Biocomposites in ocular drug delivery
Sabyasachi Maiti (2017)
Surface functionalization of methotrexate-loaded chitosan nanoparticles with hyaluronic acid/human serum albumin: Comparative characterization and in vitro cytotoxicity.
Rania A Hashad (2017)
Nanoparticles for drug delivery to the anterior segment of the eye.
D. Janagam (2017)
Preparation and evaluation of chitosan/β‐cyclodextrin magnetic nanoparticles as a photodegradable and hydrophobic drug delivery carrier
Xu Shi (2017)See more